The Combination Product Regulatory Fairness Act of 2015 is intended to improve “an outdated and inefficient regulatory process” for innovative drug and device combination products, according to Sen. Johnny Isakson, R-Ga.
Isakson cosponsored the bill with Sens. Robert Casey, D-Pa., and Pat Roberts, R-Kansas. S
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?